All COVID-19 articles – Page 37
-
NewsResearchers find new viral entryway into host cells for Covid-19
A University of Ottawa-led team has found a new viral entry for SARS-CoV-2, suggesting it may be able to use proteins to infect a wider range of cells.
-
NewsNew £1.7m containment facility will help prepare for future pandemics
A £1.7m laboratory building which will investigate infectious diseases has opened at the University of Warwick – helping to tackle some of the most globally important human diseases and prepare for pandemics of the future.
-
NewsImmune response discovery solves mystery of why colds are more common when it’s cold
Scientists say a newly discovered immune response inside the nose is suppressed by colder temperatures, offering evidence for why colds, flu and COVID-19 are more common in cooler months.
-
NewsWireless device can rapidly spot coronavirus using magnetostrictive composite plates
A collaborative research group has engineered a self-sustaining device that can immediately detect COVID-19 particles in its surroundings.
-
NewsClover’s vaccine candidate reduced household transmission of SARS-CoV-2
A collaboration between Clover Biopharmaceuticals Ltd and the International Vaccine Institute showed that a household contact was 84% less likely to get a SARS-CoV-2 infection when the infected household member had received SCB-2019 (CpG 1018/Alum) compared to placebos.
-
NewsCOVID-19 infection disrupts gut microbes, especially with antibiotics
Acute infection disrupts a healthy balance between good and bad microbes in the gut, especially with antibiotic treatment, researchers have found.
-
NewsResearchers develop tailored Covid neutralizer that can adapt to mutations
A research team at Pohang University of Science and Technology has developed a tailored COVID-19 neutralizer that can adapt to all kinds of mutations in the virus in treating the viral infection.
-
NewsNew Omicron subvariant resistant to all approved therapeutic antibodies
Rrsearchers in Germany have found that the Omicron sub-lineage BQ.1.1, currently on the rise worldwide, is resistant to all the approved antibody therapies used to treat individuals at risk for severe Covid-19 disease.
-
NewsHidden Nsp1 cavity means Covid’s Spike protein is no longer the only target
Researchers have revealed the existence of a hidden ’’pocket’ on the surface of the non-structural protein Nsp1 on the surface of the Covid-19 virus which could offer a potential drug target and alternative to the Spike protein targeted by vaccines.
-
NewsCOVID-19 reanimates latent viruses in cells – particularly in ME patients
Researchers have found that COVID-19 reactivates viruses that had become latent in cells following previous infections, particularly in people with chronic fatigue syndrome, also known as ME/CFS.
-
NewsSARS-CoV-2 alters functioning of RNA in infected cells
Researchers have shown that infection by SARS-CoV-2, the virus that causes COVID-19, changes the functioning of host cell RNA.
-
NewsCoffee compound could offer protection from catching COVID-19
Researchers have shown that a compound found in coffee could help to protect against infection by Covid-19.
-
NewsCOVID-19 virus increases risk of other infections by disrupting normal mix of gut bacteria
Infection with Covid-19 can reduce the number of bacterial species in a patient’s gut, with the lesser diversity creating space for dangerous microbes to thrive, a new study has found.
-
NewsResearchers find SARS-CoV-2 Omicron BA.2 subvariant less severe than earlier variants
team led by investigators at Massachusetts General Hospital (MGH) has determined that the SARS-CoV-2 Omicron BA.2 subvariant is less severe than the previous Delta variant and less severe to an even greater extent than the original Omicron variant.
-
NewsIntranasal COVID vaccine works against variants in animals
Researchers have developed an intranasal vaccine against Covid-19 that can fight off the original virus and two variants in hamsters.
-
NewsmRNA vaccines significantly reduce severity of Delta, Omicron COVID-19 infections
People who have received several doses of an mRNA COVID-19 vaccine are more likely to have milder illnesses if infected with Delta or Omicron variants than those who are unvaccinated.
-
NewsNew Omicron subvariant largely evades neutralizing antibodies, raising spectre of increased Covid infections this winter
A study at Karolinska Institutet in Sweden shows that the coronavirus variant BA.2.75.2, an Omicron sublineage, largely evades neutralizing antibodies in the blood and is resistant to several monoclonal antibody antiviral treatments.